Back to Search Start Over

LBA88 Belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC): Randomized open-label phase III LITESPARK-005 study.

Subjects

Subjects :
*RENAL cell carcinoma
*EVEROLIMUS

Details

Language :
English
ISSN :
09237534
Volume :
34
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
173099662
Full Text :
https://doi.org/10.1016/j.annonc.2023.10.090